Efficacy of chemotherapy and palliative hypofractionated radiotherapy for cats with nasal lymphoma

Nasal lymphoma (NL) is the most common nasal tumor in cats, and radiotherapy, chemotherapy, or a combination of these treatments have been described as the treatment for this disease. However, the previous studies included various machines and protocols of radiotherapy. Therefore, we aimed to retros...

Descripción completa

Detalles Bibliográficos
Autores principales: NAKAZAWA, Maho, TOMIYASU, Hirotaka, SUZUKI, Kanako, ASADA, Hajime, FUJIWARA-IGARASHI, Aki, GOTO-KOSHINO, Yuko, OHMI, Aki, OHNO, Koichi, FUJITA, Michio, TSUJIMOTO, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025413/
https://www.ncbi.nlm.nih.gov/pubmed/33473067
http://dx.doi.org/10.1292/jvms.20-0464
Descripción
Sumario:Nasal lymphoma (NL) is the most common nasal tumor in cats, and radiotherapy, chemotherapy, or a combination of these treatments have been described as the treatment for this disease. However, the previous studies included various machines and protocols of radiotherapy. Therefore, we aimed to retrospectively compare the prognosis among cases treated with palliative hypofractionated radiotherapy, chemotherapy, and a combination of them with united machine and protocol of radiotherapy. When compared overall survival and progression free survival, there was no significant difference among these three groups. The data of this study suggested that similar efficacy could be achieved by palliative hypofractionated radiotherapy, chemotherapy, or a combination of them.

Ejemplares similares